The spread of coronavirus worldwide is not fading. In the aftermath of the pandemic, the dental industry is also hit by a sharp drop in the number of patients, business deterioration, and concerns over an infection. Patients strongly perceive themselves as vulnerable to respiratory droplet transmission during dental treatment. Therefore, to reduce the level of anxiety and increase dental visits, perceivable differentiation is necessary for patients.

With hygiene and infection control being more critical than ever, DENTIS is making all-out efforts to ensure thorough quality control and flawless process implementation on implants, as indicated by the flagship brand ‘Cleanlant.’ It has established separate facilities for sterilization and cleaning, maintaining a consistently clean implant quality. It is also well received in the global market.

‘SQUVA,’ an implant surface treatment activation device that enhances the hydrophilic effect of the implant surface, is also drawing attention as an indispensable item for clean clinics. ‘SQUVA’ not only helps the implant to be placed in the oral cavity in a sterile condition through UV disinfection right before surgery, but also effectively prevents cross-infection by installing motion detection sensors to reduce unnecessary contact during the procedure.

In addition, DENTIS also introduced ‘STR Solution,’ a room disinfectant that enables rooms to be clean and pleasant for medical treatment and surgery. Notably, last December, ‘STR Solution’ was recognized as the first in Korea to achieve the international good laboratory practice (GLP) certification for its disinfecting ability to remove even the COVID-19 virus.

DENTIS sympathizes with the concerns and risk of infection from the coronavirus that the dental clinics are facing around the world, and plans to introduce various items that will completely transform the waiting room, treatment room, and operating room into clean areas.